NICE Stuns Merck With Demand For Additional Daxas Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
NICE says it wants Merck to carry out an additional clinical trial of Daxas in conjunction with triple therapy for COPD, if the company is to get its drug into the NHS.